1999 to 2020 Saw Decline in Menopausal Hormone Therapy Use
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 30, 2024 -- From 1999 to 2020, there was a decrease in menopausal hormone therapy (MHT) use among postmenopausal women, according to a study published online Sept. 27 in JAMA Health Forum.
Lin Yang, Ph.D., from Cancer Care Alberta in Calgary, Canada, and colleagues examined trends in and correlates of MHT use among postmenopausal women in the United States using data from the nationally representative National Health and Nutrition Examination Survey from 1999 to March 2020. Data were analyzed for 13,048 U.S. postmenopausal women.
The researchers found that the prevalence of MHT use decreased among women of all ages from 26.9 to 4.7 percent in 1999 and 2020, respectively. MHT use was higher among women aged 52 to 65 years until 2002; since 2005, MHT use has been higher among those aged younger than 52 years. For women aged younger than 52 years, 52 to younger than 65 years, and 65 years and older, MHT use decreased by 23.5, 31.4, and 10.6 percent, respectively. Decreases in prevalence of MHT use were seen for Hispanic women (13.8 to 2.6 percent), non-Hispanic Black women (11.9 to 0.5 percent), and non-Hispanic White women (31.4 to 5.8 percent); prevalence was consistently highest for non-Hispanic White women. Among all racial and ethnic groups, the prevalence of MHT use varied by family income-to-poverty ratio and health insurance coverage.
"Discussions and policy on MHT use need to take into consideration sociodemographic factors such as age, race and ethnicity, income, and education," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-01 06:00
Read more
- Minimally Invasive Lumbar Decompression Alleviates Pain From Lumbar Spinal Stenosis
- FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara
- Team Sports, but Not Overall Physical Activity, in Young Childhood Linked to Later Executive Function
- Weight Loss Brings Americans Big Health Care Savings
- Family History of Mental Illness Tied to Aggression in Those With CTE
- President-Elect Trump Names His Picks to Head the CDC and FDA
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions